Maintaining ‘standards’ for biosimilar monoclonal antibodies

被引：0
|
作者：
Sandra Prior
Clive Metcalfe
Simon E. Hufton
Meenu Wadhwa
Christian K. Schneider
Chris Burns
机构：
[1] National Institute for Biological Standards and Control (NIBSC),
[2] Twincore Centre,undefined
[3] Hannover Medical School,undefined
来源：
Nature Biotechnology | 2021年 / 39卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：276 / 280
页数：4
相关论文
共 50 条
  • [31] Production of monoclonal antibodies for measuring Avastin and its biosimilar by Sandwich ELISA
    Li, Maohua
    An, Wenqi
    Wang, Lan
    Zhang, Feng
    Li, Jianli
    Zhang, Yongchao
    Li, Yingzi
    Li, Hongzhen
    Ren, Wenlin
    Zhao, Rongqing
    Xia, Chenxi
    Sun, Le
    JOURNAL OF IMMUNOLOGICAL METHODS, 2019, 469 : 42 - 46
  • [32] New frontiers in oncology: biosimilar monoclonal antibodies for the treatment of breast cancer
    Thill, Marc
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (03) : 331 - 338
  • [33] Assessing immunogenicity of biosimilar therapeutic monoclonal antibodies: regulatory and bioanalytical considerations
    Chamberlain, Paul
    BIOANALYSIS, 2013, 5 (05) : 561 - 574
  • [34] Biosimilar structural comparability assessment by NMR: from small proteins to monoclonal antibodies
    Boštjan Japelj
    Gregor Ilc
    Jaka Marušič
    Jure Senčar
    Drago Kuzman
    Janez Plavec
    Scientific Reports, 6
  • [35] Ethnic sensitivity assessments in biosimilar monoclonal antibodies clinical development programmes: necessary or not?
    Athalye, Sandeep
    Baruah, Dev
    Mittra, Shivani
    Ranpura, Ankit
    Kumar, Kuldeep
    Wolff-Holz, Elena
    GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2023, 12 (02):
  • [36] PERCEPTIONS OF BIOSIMILAR MONOCLONAL ANTIBODIES AMONGST EU5 BUDGET HOLDERS
    Gardiner, R. B.
    VALUE IN HEALTH, 2015, 18 (03) : A200 - A201
  • [37] Biosimilar Monoclonal Antibodies for Inflammatory Bowel Disease: Current Comfort and Future Prospects
    Krisztina B. Gecse
    Péter L. Lakatos
    Drugs, 2016, 76 : 1413 - 1420
  • [38] Temperature Upshifts in Mammalian Cell Culture: A Suitable Strategy for Biosimilar Monoclonal Antibodies?
    Marschall, Lukas
    Gottimukkala, Chitti Babu
    Kayal, Biswajit
    Veeraraghavan, Veerabhadra Madurai
    Mandal, Samir Kumar
    Bandyopadhyay, Suman
    Herwig, Christoph
    BIOENGINEERING-BASEL, 2023, 10 (10):
  • [39] Regulatory Perspective of International Agencies for Development of Biosimilar Products (Monoclonal Antibodies): An Overview
    Sharma, Atul
    Khante, Shyam
    Mahadik, Kakasaheb R.
    Gaikwad, Vinod L.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (05) : 965 - 977
  • [40] Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory Perspective
    Pekka Kurki
    Sean Barry
    Ingrid Bourges
    Panagiota Tsantili
    Elena Wolff-Holz
    Drugs, 2021, 81 : 1881 - 1896
12345